Recent calculations by Viridian Capital Advisors have shed light on the significant impact that eliminating Section 280e could have on the cannabis industry. This impact could potentially outweigh the effects of the SAFE Act and a TSX uplisting. Section 280e, a provision in the Internal Revenue Code, restricts businesses from deducting ordinary expenses associated with the “trafficking” of Schedule I or II substances, as defined by the Controlled Substances Act.
Ladies and gentlemen, we have a new contender for the most audacious cannabis caper of…
How much should an ounce of weed cost? As the U.S. cannabis market surges past…
Find the best high-potency hemp products of 2025. Leafly reviewed popular hemp products & chose…
A breakdown of the situation regarding hemp, cannabis, and THCA—courtesy of The Hemp Doctor. The…
Well, folks, it looks like Donald Trump might be the best thing to happen to…
In a policy memo that reeks of entitlement, the American Beverage Licensees (ABL) trade association…